RNA Targeting Small Molecule Drug Discovery Market to be dominated by Cancer Segment through 2028
The increasing prevalence of
RNA-related diseases is expected to drive the growth of Global RNA Targeting
Small Molecule Drug Discovery Market during the forecast period, 2024-2028.
According to TechSci Research
report, “RNA Targeting Small Molecule Drug Discovery Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F,” the
Global RNA Targeting Small Molecule Drug Discovery market is anticipated to
grow at an impressive rate in the forecast period, 2024-2028. This
can be ascribed to the growing demand for new drugs owing to the high burden of
chronic and infectious diseases and the increased research and development
costs. Additionally, the growing demand for generics and biosimilars are the
major factors driving the growth of the market during the forecast period.
Also, the growing demand for innovative and effective medicine will further
boost the growth of the global RNA Targeting Small Molecule Drug Discovery
market in the forecast period. Besides, governments around the world are
providing support for the development of the healthcare industry, including
funding for research and development, which is driving the demand for the
Global RNA Targeting Small Molecule Drug Discovery Market during the forecast
period. Similarly, growing research centers and biopharmaceuticals sectors are
the major factors driving the growth of the market over the years.
However, small molecules can
bind to multiple targets, including unintended targets, which can lead to
unwanted side effects which can slow down the growth of the global RNA
Targeting Small Molecule Drug Discovery market in the forecast period. Also,
RNA-targeted small molecule drugs need to be delivered to the target cells and
tissues to exert their therapeutic effects. Delivering small molecules to
specific cells or tissues can be challenging, which may hamper the growth of
the market during the forecast period. Similarly, RNA-targeted small molecule
drugs face competition from other therapeutic modalities, including monoclonal
antibodies, gene therapy, and RNA-based therapeutics which may restrict the
growth of the market.
Browse over XX market data
Figures spread through XX Pages and an
in-depth TOC on "Global RNA Targeting Small Molecule Drug Discovery Market.”
Global RNA Targeting Small
Molecule Drug Discovery market can be segmented by Indication, End User, Region
and Competitive Landscape.
Based on the Indication, the
global RNA Targeting Small Molecule Drug Discovery Market can be segmented into
Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others.
Cancer segment dominated the market in 2022 and is expected to continue
maintaining its dominance throughout the forecast period. This can be ascribed
to the growing prevalence of cancer diseases due to consuming alcohol and
smoking along with growing research and development for developing new drugs.
Also, the high prevalence of chronic diseases such as diabetes, HIV, and other
diseases is further contributing to the demand for developing innovative
therapies which will further drive the growth of the market during the forecast
period.
Based on End Users, the market
can be grouped into Pharmaceutical and Biopharmaceutical Companies, Academic
and Research Institutes, Others. The Pharmaceutical and Biopharmaceutical
Companies segment is expected to dominate during the forecast period on account
of the increasing investments by government and private organizations for development
of new therapies and drugs.
Major companies operating in the
Global RNA Targeting Small Molecule Drug Discovery Market are:
- Accent Therapeutics.
- Anima Biotech Inc.
- Arrakis Therapeutics.
- Epics Therapeutics.
- Expansion Therapeutics.
- Hoffmann-La Roche Ltd.
- H3 Biomedicine Inc.
- PTC Therapeutics.
- Servier Laboratories.
- Skyhawk Therapeutics, Inc.
For instance, in July 2022,
Dotmatics, one of the leaders in the research and development of scientific
software connecting science, data, and decision-making, released a
small-molecule drug discovery solution. It is an integrated scientific research
and development platform with pre-configured workflows and expanded data
management capabilities.
For instance, in August 2021,
Insilico Medicine, one of the industry leaders in end-to-end artificial
intelligence for target discovery, small molecule chemistry, and clinical
development, and Usynova signed a strategic cooperation to advance the
development of small molecule innovative therapies.
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“North America is expected to
dominate in the Global RNA Targeting Small Molecule Drug Discovery market due
to the presence of many pharmaceutical and biotechnology companies in the
region, as well as significant government funding for research and development
in the life sciences. Similarly, the growing demand for RNA Targeting Small
Molecule Drug Discovery , as these technologies are critical for developing new
treatments and therapies along with the growing prevalence of chronic diseases
such as cancer is expected to create lucrative growth in the market during the
forecast period. Also, growing government funding for healthcare infrastructure
and a large and rapidly expanding population is expected to drive the growth of
the market during the forecast period. Furthermore, increased R&D spending
in RNA molecule research and increased market demand for high-quality
analytical equipment for RNA analysis will further create lucrative
opportunities for market growth,” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based global management consulting firm.
“RNA Targeting Small Molecule
Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028F, Segmented By Indication (Cancer,
Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others), By End
Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research
Institutes, Others), By Region and By Competition,” has
evaluated the future growth potential of global RNA Targeting Small Molecule
Drug Discovery market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision-makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the Global RNA Targeting
Small Molecule Drug Discovery market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com